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Abstract
One of the challenging problems in biology and medicine is exploring the underlying mechanisms of genetic diseases.
Recent studies suggest that the relationship between genetic diseases and the aging process is important in understanding
the molecular mechanisms of complex diseases. Although some intricate associations have been investigated for a long
time, the studies are still in their early stages. In this paper, we construct a human disease-aging network to study the
relationship among aging genes and genetic disease genes. Specifically, we integrate human protein-protein interactions
(PPIs), disease-gene associations, aging-gene associations, and physiological system–based genetic disease classification
information in a single graph-theoretic framework and find that (1) human disease genes are much closer to aging genes
than expected by chance; and (2) diseases can be categorized into two types according to their relationships with aging.
Type I diseases have their genes significantly close to aging genes, while type II diseases do not. Furthermore, we examine
the topological characters of the disease-aging network from a systems perspective. Theoretical results reveal that the
genes of type I diseases are in a central position of a PPI network while type II are not; (3) more importantly, we define an
asymmetric closeness based on the PPI network to describe relationships between diseases, and find that aging genes make
a significant contribution to associations among diseases, especially among type I diseases. In conclusion, the network-
based study provides not only evidence for the intricate relationship between the aging process and genetic diseases, but
also biological implications for prying into the nature of human diseases.
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Introduction
One of the challenging problems in biology and medicine is to
explore the underlying mechanisms of genetic diseases. During the
last decades, great efforts have been devoted to identifying disease-
related genes and disease-related pathways [1,2]. Progresses have
been achieved both in understanding the mechanisms of specific
diseases and in identifying key proteins as potential drug targets.
However, these single gene-based methods are far from enough in
elucidating complex diseases. For example, Alzheimer disease, a
kind of neurological disease, is related with at least 12 genes
(Online Mendelian Inheritance in Man, OMIM). The mechanism
of this kind of heterogeneity diseases cannot be totally uncovered
by the conventional gene-by-gene or pathway-by-pathway meth-
ods because most cellular components exert their functions
through complicated networks [3] of signal transductions [4],
gene regulations [5], metabolic reactions [6], and protein
interactions [7].
Network-based methods to study human genetic diseases appear
along with the concept of ‘‘omics’’ and the growth of high-
throughput data [4,8–15]. For example, Jonsson and Bates studied
the global topological features of cancer proteins in a predicted
human protein-protein interaction (PPI) network [9]. In their
work, features of diseases were uncovered from a global analysis,
but they did not consider the effect of essential genes. Combining
with essential genes, Goh. et al. found some different conclusions
in a human disease network [11].
In this paper we focus on aging which is one of the important
factors to induce diseases [16,17]. Research on aging is helpful to
understand the nature of diseases by integrating disease and aging
information at a network level. We note that aging is another
complex process in addition to genetic diseases controlled by both
environmental and genetic factors. In the past few years,
researchers began to investigate aging process on a systems level
[18–24]. For instance, Budovsky et al. compiled a complete list of
longevity genes from different species, mapped them to 211
orthologs in human, and constructed a human longevity network
using protein-protein interactions [25]. Here, we highlight the
intricate relationships between aging and diseases since the
process of aging is a gradual decay of homeostatic mechanisms
affecting our susceptibility to disease and our ability to recover
from illness and other stressors. We note that their relationships
have been pointed out for a long time, but seldom been
investigated from the systems perspective. Recently, some
progresses are reported. Budovsky et al. verified the existence of
evolutionary and molecular links between longevity and cancer
PLoS Computational Biology | www.ploscompbiol.org 1 September 2009 | Volume 5 | Issue 9 | e1000521[26]. Wolfson et al. highlighted the importance of some pathways
by combining the network of human age-related disease proteins
and longevity-associated proteins, especially through those hubs
involved in the crossroad of longevity and age-related disease
network [27].
At the same time, there is a pressing need to associate genetic
diseases and aging at a network level. Firstly, only a small number
of well known age-associated diseases have been considered, and
thousands of different kinds of genetic diseases remain
untouched. Secondly, longevity genes are actually not equal
to aging genes. Longevity genes are alleles that have been
observed to have higher frequency in centenarian than others.
Different from longevity genes, aging genes are those genes that
have been identified in human or animal models to have the
ability to change the aging process as a whole, or at least to a
large degree [28]. Combining genes that are related to aging
process with diseases may reveal the nature of complex diseases.
Thirdly the problem how close the genetic diseases and aging
process are and why they are close to each other have not been
solved until now [29].
In this paper, we analyze the relationships between aging and
disease genes by integrating human PPI, known disease-gene
associations and known aging-gene associations into a disease-
aging network (DAN), then classify diseases genes based on the
derived network, and further quantify the contribution of aging
genes to association between each pair of diseases. Specifically,
we firstly construct a DAN and analyze its topological properties.
Then we identify the relationship between aging genes and
disease genes, and categorize diseases into two types: type I
disease genes are significantly close to aging genes, but type II
disease genes are not. Furthermore, we examine the features of
topology and structure for the disease-aging network from a
systems perspective. Theoretical results show that type I diseases
are in a central position of a PPI network while type II are not.
Moreover, we define an asymmetric closeness based on PPI
network trying to describe close associations between diseases,
and find that aging genes make a significant contribution to most
of disease associations comparing with genes having same
number of links.
Results
The disease-aging network
We construct a network of aging and genetic diseases named
disease-aging network (DAN), which is a connected PPI network
whose nodes are known aging and disease genes (Figure 1A).
According to OMIM and GenAge, there are 1,438 genes related
to aging or diseases (Supplementary Table S1 and Supplementary
Table S2) in addition. We map all these genes to nodes in the PPI
network of Human Protein Reference Database (HPRD) [30], and
then extracted the maximum connected component as DAN. As
shown in Figure 1A, aging genes are marked by nodes with black
border while disease genes are colored according to their
categories of diseases, which is a curated classification of all
OMIM diseases [11]. If one gene is reported to be related with
more than one category, it will be colored in pink (labeled as
‘‘MD’’ in Figure 1A). The size of nodes and the color of edges
correspond to the degree and betweenness centrality [31]
respectively.
As shown in Figure 2A, DAN has 1108 nodes, and it is much
larger than expected by chance (Instead of the human PPI
network, 1000 random degree-conserved networks are chosen as
control, and the number of nodes in the maximum connected
component is 1037.8614.8 with p-value ,1.0e-6). This demon-
strates that disease/aging related genes tend to be connected in the
network. Furthermore, DAN has 3221 edges, and it is much
denser than expected by chance with a p-value ,1.0e-10 (As
shown in Figure 2B, 1000 random degree-conserved networks are
chosen as control, and the number of edges within the maximum
connected component is 2565.3638.0).
The average length of shortest paths among aging genes, disease
genes, aging or disease genes, aging and disease genes in the
human protein interaction network are also compared. As shown
in Figure 2C, on average, any two nodes in the human protein
interaction network are connected via 4.360.1 links, while the
average distance between aging or disease genes (i.e. genes in
DAN) is 4.0. This means that most disease and aging genes are
very closely connected.
Also, the degree distribution follows P(k)!k{1:55 (Figure 1B),
so it is a scale free [32] network, which shows an unusual degree of
robustness, the ability of its nodes to communicate being
unaffected by even unrealistically high failure rates [33]. Albert
et al. also proved that networks in general are very vulnerable to
attacks aimed at highly connected nodes (hubs). In the disease-
aging network (Figure 1A), average degree of nodes with black
borders is 14.3, which is significantly larger than that of disease
genes 4.9 with a p-value 8.4e-36 (Wilcoxon rank sum test). This
fact implies the importance of aging genes in this network’s
connectivity.
Furthermore, we calculated the clustering coefficient of each
node in the network. Clustering coefficient is a measure of the
tendency of proteins in a network to form clusters or groups [32].
Figure 1C shows that clustering coefficient in DAN decreases with
the increase of nodes’ degree, indicating that DAN has a
hierarchical structure. In a hierarchical network, a high degree
hub connects some local communities, suggesting that the network
has two levels of organization, i.e. local clustering, potentially
representing some locally affecting diseases; and more global
connectivity mediated via aging genes, conceivable as higher-order
communication points between different diseases like date hub
described in PPI networks [34,35]. The topological coefficient is a
relative measure for the extent to which a gene in the network
shares interaction partners with other proteins [6]. As shown in
Figure 1D, also the topological coefficient decreases with the
Author Summary
Explaining the molecular mechanisms of complex genetic
diseases is a crucial step for curing them. Extensive studies
have suggested close relationships between the aging
process and genetic diseases. As a result, incorporation of
the aging process in studying diseases may provide
important insights both in biology and medicine. Here
we construct a disease-aging network in humans to
systematically explore and visualize the intricate relation-
ships between diseases and the aging process. Instead of
focusing on a specific disease or a single gene, we put all
complex diseases and the aging process together and
probe the interactions among the disease genes and aging
genes under the network concept. By checking the
network topological properties, we reveal that human
disease genes are much closer to aging genes than
expected by chance. Further analysis categorizes diseases
into two types according to their relationships with aging.
Our study provides important evidence to associate
diseases and the aging process at the system level and
helps to further our understanding in the molecular
mechanisms of complex diseases.
The Disease-Aging Network
PLoS Computational Biology | www.ploscompbiol.org 2 September 2009 | Volume 5 | Issue 9 | e1000521Figure 1. The disease-aging network (DAN) and its topological properties. (A) A protein-protein interaction network connecting aging and
disease. Non-disease aging genes are colored in grey and disease genes are colored by their types. MD in the figure means that the genes are
involved in multiple gene sets. Refer to Materials and Methods for detailed information about aging genes and classification of disease genes. (B–D)
Basic network features of disease aging network. Refer to Materials and Methods for detailed information about definition of network features. (E)
Box plot for closeness centrality of disease and aging genes in DAN. Refer to Materials and Methods for detailed information about definition of
different network centrality measures.
doi:10.1371/journal.pcbi.1000521.g001
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genes do not have more common neighbors than genes with fewer
links. This fact indicates that the hubs may not locate together in a
few densely connect modules like cliques in DAN [7].
Aging genes (nodes with black borders) tend to locate in the
central part of DAN. To measure ‘central’ quantitatively, we use
closeness centrality [36], which is defined as the reciprocal of the
average shortest path length. As shown in Figure 1E, average
closeness centrality value of aging genes is much greater than that
of disease genes (p-value ,5e-40). In addition to closeness
centrality, we have also calculated other existing centrality
measures (refer to Materials and Methods). We found that all
these centrality measures support our observation that aging genes
show much stronger centrality than disease genes. Actually, all the
p-values are less than 1e-20 by Wilcoxon rank sum test (see
Supplementary Figure S1 for details).
The above discussion reveals that there are close implications
among disease/aging genes, and then we will ask how significant
the relationship is.
Close relationships between aging and diseases
The number of overlapping genes (colored black border genes)
of aging and disease were calculated. In all 226 aging genes in
human PPI network, 105 are reported to be related with some
kind of diseases (Figure 3B). This is three times as many as the
expected number. We observe significant overlap between aging
genes and disease genes (p-value ,1e-20).
We believe the above observation is due to the close
relationships between aging and diseases. To claim that, we need
to exclude two alternative factors, which may implicitly contribute
to the above observation. One is that the observed overlap is
caused by negative set, i.e. the genes treated as non-aging genes or
Figure 2. The further analysis of disease aging network (DAN). (A) The number of vertexes of DAN is significantly larger than that of degree-
conserved random networks (p-value ,1.0e-6). (B) The number of edges of DAN is significantly larger than that of degree-conserved random
networks (p-value ,1.0e-10). The procedure to generate the random networks is described in Materials and Methods. (C) Comparison of average
lengths of shortest paths among aging genes, disease genes, aging or disease genes, aging and disease genes, and random genes in the human
protein interaction network from HPRD database. The normal distribution is used to fit the distance between genes. (D) Classification of aging genes
by their supporting evidences in GenAge database. All aging genes are classified into eight types (x-axis). Types 1–6 are supported by direct and
high-confident evidences while Types 7 and 8 are supported by indirect evidences. Given a particular type of aging gene, the difference of its
percentages (y-axis) in the aging-disease overlap gene set and whole aging gene set indicates whether or not the aging gene set possesses potential
bias to diseases.
doi:10.1371/journal.pcbi.1000521.g002
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PLoS Computational Biology | www.ploscompbiol.org 4 September 2009 | Volume 5 | Issue 9 | e1000521Figure 3. The core network. (A) The core network of DAN. Each node in the network is both related to aging and some kind of diseases. (B) The
number of overlapping genes between aging and diseases in the human PPI network. (C) Pie graph to show number of genes in different diseases.
(D) Grouping diseases into two groups: significant age-related diseases and others. Fold enrichment ratio (FER) is also marked when some disease is
observed to be significant. Refer to Materials and Methods for detail. (E) Age-related diseases (ARD) show higher closeness centrality than non-age-
related disease (NARD) genes. ‘‘Disease’’ means all disease genes, and ‘‘all genes’’ means all genes in the human PPI network. ‘‘mean hprd cc’’ stands
for mean closeness centrality in the human PPI network.
doi:10.1371/journal.pcbi.1000521.g003
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negative set will contribute much to the significance. To reduce
this kind of bias, we also choose all human genes and non-essential
genes in the human PPI network as a universal set (also called the
sample space, is the one that contains all conceivable genes). In
these two sets, fold enrichment ratios (defined as the ratio of
observed overlap to expected overlap) are 6.7 and 3.6 respectively
(Supplementary Figure S2), with corresponding p-values 3e-55
and 7e-11 respectively. This demonstrates that the number of
overlapping genes in aging and disease is significantly enriched.
Another legitimate concern is the possible bias in defining
‘‘aging genes’’, i.e. aging genes defined in GenAge includes genes
already implicated in human age-associated diseases, and this may
artificially inflate the linkage between aging genes and disease
genes. To test whether aging genes and disease genes are still
significantly overlapped when there are no biases in aging gene set,
we carried out three experiments with alternative selection criteria.
We classified all aging genes into eight types (Supplementary
Table S1) according to their evidences to be selected to GenAge
database to check which type tends to have bias. In the eight types
of aging genes, types 7 and 8 have relatively low confidence
comparing with types 1–6. In the first experiment, we excluded
genes with low confidence, i.e. type 7 and type 8. Then there are
139 aging genes. We repeated the same procedure to check the
link between aging process and diseases. We found again that they
are significantly closely related (p-value ,1e-10).
On the other hand, considering the possible bias to disease, we
counted the percentages of types 1–8 aging genes in the whole
aging gene set and aging-disease overlapping gene set and we
plotted the results in Figure 2D. By comparing the differences of
their percentages for each type, we found that types 1, 2, and 7
have relatively higher probability to have bias to disease genes. As
the second experiment, we excluded those gene subsets in GenAge
with possible bias to human diseases, i.e. types 1, 2, and 7. Then
we have a new aging gene subset with 160 aging genes. We
repeated the same procedure to check the link between aging
process and diseases. We found again that they are significantly
closely related (p-value ,1e-10).
Furthermore, we did extra control study as the third experiment
by following the same procedure on the longevity gene set defined
in GenAge database. And the experimental results support our
main conclusion too. In particularly, we chose 94 longevity genes
from GenAge database. Among the set, there are 63 genes that are
closely related to some kind of diseases. The significant enrichment
(fold enrichment 4.6, p-value ,1.5e-12) also confirms our above
conclusion.
In addition to the gene overlap, we checked the relationship
between aging and diseases from the view of interactions. As
shown in Supplementary Figure S2D, there are total 34853
interactions in the human PPI network, among which 965 are
among aging genes and 1894 are among disease genes. On
average, the number of interactions between both aging and
disease genes is 52.4. But the observed value is 233, nearly 4.5
times as many as expected by chance. (p-value ,7e-70).
Aging and diseases are closely related not only in overlapping of
genes or interactions but also in network topology. We calculated
the interacting partners of each aging gene on the human PPI
network and in 1,000 randomly generated network without
changing node degree. We found the percentage of disease genes
in all aging partners is significant higher than random no matter
the aging genes are hubs or not (Table 1). This fact indicates that
aging genes tend to interact with disease genes. Furthermore, as
more strict control, we randomly selected a set of 226 disease genes
from the whole 1,317 disease genes (matching degrees with aging
gene set). We then calculated the number of disease partners of
this disease gene set and we repeated this procedure for 1,000
times. The average value for the number of disease partners is
7.660.2 for the 226 disease genes, which is significantly smaller
than that of 226 aging genes 9.4 (p-value ,1e-10). As another
control, cancer genes are used instead of aging genes to see if the
above observation still holds. Our conclusion is that generally
cancer genes are not significant close to other disease genes.
Cancer genes with degree 20–50 are significantly closer to other
disease genes than expected by chance, while cancer genes with
degree less than 20 or larger than 50 are close to other disease
genes but these relations are not statistically significant (Supple-
mentary Table S3).
In summary, we have observed significantly close relationship
between aging and disease genes in the network level. Versus
random expectation, genes regulating aging process are more
likely to relate to some kinds of diseases, and also the protein
product of aging genes and disease genes more likely have physical
interactions.
Two types of diseases
It has been proved that diseases are close to aging, but is this
observation true for all kinds of diseases? To answer this question,
we extracted and analyzed disease-aging overlapping part. There
are totally 101 nodes (Here, we only used the 101 genes with
edges, and the 4 genes without any edges were discarded.) with
233 edges in this core network (Figure 3A). Its maximum
connected component consists of 86 nodes and 232 edges with
diameter 7 and average shortest path 3.0. The clustering
coefficient [37] is 0.25, which is significantly higher than 0.15 in
DAN (p-value ,10e-6). Figure 3C shows the percentage of all
kinds of diseases in overlapping genes. Cancer with 36 genes,
neurological diseases with 19 genes, and endocrine diseases with
14 genes take main part of overlapping genes, showing their
special relationship with aging process. To show the statistical
significance, the p-values for diseases overlapping with aging and
their fold enrichment ratios (FER) were calculated. In addition to
cancer, neurological disease and endocrine diseases discussed
above, nutritional disease, developmental disease and other three
kinds of disease have p-values (refer to the p-value calculation in
Materials and Methods) less than 0.01 (Figure 3D). We call these
diseases as age-related diseases (ARD), and their related genes as
ARDG. At the same time, some disease genes are observed to have
less or even no overlapping with aging. We call the complemen-
tary set of ARD as non-age-related diseases (NARD), and their
genes as NARDG.
Table 1. Interacting Partners.
Degree of aging
genes
Average
degree Disease genes
Observed Random p-value
,20 9.38 2.51 1.99 7.3e-8
20–50 33.33 8.53 7.05 7.8e-7
50–100 69.27 17.49 14.52 1.9e-8
.100 139.81 33.86 28.82 1.4e-7
Observed number of disease genes in aging genes’ interacting partners is
always larger than that of random control, no matter if they are hubs or not.
Here, one thousand degree-conserved random networks are chosen as control.
P values are obtained under the assumption of normal distribution.
doi:10.1371/journal.pcbi.1000521.t001
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different features in several ways. Firstly, ARDG are central in
human PPI network, while NARDG are not. To validate this, we
compared closeness centrality of ARDG, NARDG, all disease
genes, and all genes in the human PPI network (Figure 3E).
Disease genes have a significantly higher mean closeness centrality
than NARD genes (p-value ,8e-6), and a significantly lower one
than ARD genes (p-value ,6e-4). Hence, age-related diseases tend
to attack center of the human protein network, while non-age-
related diseases have not such feature. Without considering the
network topological features, another way to measure importance
of gene is to check whether it is essential for survival. A gene is
called an essential gene if knocking down it causes death. The
percentage of essential genes in ARDG is 50.3%, which is
significantly higher than that in NARDG 32.8% (p-value ,1e-15).
Secondly, ARDG and NARDG have different functions in cells.
We checked the GO enrichment of two groups of genes. P-value
for both overrepresentation and underrepresented were calculat-
ed. Gene Ontology Annotation (GOA) items with different
performances in ARD and NARD are listed in Table 2. As
shown in this table, ARDGs are significantly overrepresented in
nucleic acid binding, nucleus, oxidoreductase activity, transcrip-
tion regulator activity and macromolecule metabolic process,
while NARDs are involved into several different functions such as
catalytic activity, transporter activity, and so on.
Finally, ARDG and NARDG show different feature in evolution
process. To compare evolutionary rate of these two groups of genes,
we used the value of dN=dS. Interestingly, the dN=dS mean value
of ARDG is 0.1731, which is significantly lower than that of
NARDG (0.1926), and the corresponding p-value is 0.008 (rank
sum test). This result shows that age-related disease genes are more
conserved than non-age-related disease genes.
Aging genes: the bridge of age-related diseases
Further, we asked what kind of close relationship aging genes
and disease genes have. With this question in mind, we firstly
investigate the association among different diseases. The relation-
ships among different diseases have been emphasized and utilized
in some recent researches. Goh et al. connect two diseases with an
edge if they have common disease genes to construct the human
disease network [11], and Wu et al. defined the closeness of
different phenotypes according to their corresponding genes
distance on the PPI network [38].
We developed a novel quality index to denote network
association between diseases. Suppose that disease i is related to
n genes, while disease j is related to m genes, then the association
from disease j to disease i is defined as the mean closeness between
each disease i related gene and disease j. Closeness between a gene
and disease j is further defined as the maximal closeness between
that gene and each disease j related gene on PPI network (see
Materials and Methods for detail). We noted that the association
from disease j to disease i is not equal to that from disease j to
disease i. Furthermore, in order to obtain significance of observed
association value, we calculated Z-score of each pair of diseases by
choosing their association values on 1,000 random degree-
conserved network as control. The resulting Z-scores reflect
strength of association between each pair of the 20 kinds of
diseases (Supplementary Figure S3).
Based on this definition, we can investigate the contribution of
aging genes to association between different diseases. Interestingly,
when we remove all aging genes from the human PPI network, the
strength of association between most diseases, especially ARD,
becomes significantly smaller than that when we randomly remove
genes with matching degree (refer to Materials and Methods for
method to generate genes with matching degree). To illustrate the
Table 2. Different GOA enrichments of ARD and NARD.
GO-ID ARD NARD Description
p-value #Genes p-value #Genes
3676 1.4e-4 156 1.1e-10(under) 68 nucleic acid binding
5634 3.2e-13 193 2.2e-7(under) 79 nucleus
6139 5.0e-19 194 3.7e-03(under) 113 nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
5622 1.1e-9 411 .0.01 391 intracellular
16301 2.4e-8 63 .0.01 44 oxidoreductase activity
30528 5.3e-15 112 .0.01 49 transcription regulator activity
43170 3.4e-11 313 .0.01 295 macromolecule metabolic process
3824 .0.01 206 1.6e-8 282 catalytic activity
5478 .0.01 58 3.9e-10 101 transporter activity
9055 .0.01 12 8.3e-7 56 catabolic process
9056 .0.01 29 2.5e-5 85 biosynthetic process
9405 .0.01 2 7.6e-7 20 cell surface
9929 .0.01 11 2.9e-7 60 ion transmembrane transporter activity
15075 .0.01 36 8.5e-6 37 channel activity
5941 .0.01 1 4.6e-4 6 unlocalized protein complex
16740 .0.01 76 1.2e-5 129 hydrolase activity
16787 .0.01 88 1.9e-5 20 lyase activity
16874 .0.01 13 1.4e-7 113 cell differentiation
ARDG and NARDG show different in GOA enrichment. ARDG shows special overrepresentation in nucleus related functions. P values labeled with ‘‘under’’ mean
underrepresentation, while others stand for overrepresentation.
doi:10.1371/journal.pcbi.1000521.t002
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genes as minus ten-based logarithm p-value of each pair of diseases
by choosing randomly removing pseudo aging genes for 1,000
times as control (see Materials and Methods for detail). The
resulting bridgenesses of aging genes between different diseases are
shown in Figure 4A. In this figure, 20 kinds of diseases are ordered
in according to their fold enrichment ratio of overlapping genes
with aging. This result shows that aging genes take a special role in
bridging disorders, especially ARD.
Will this observation still holds if we consider cancer genes
instead of aging genes? Our conclusion is that cancer genes do not
make a significant contribution to associations among most of
diseases by the closeness analysis in PPI network (Supplementary
Figure S4). This is fundamentally different from aging gene set.
To show the bridgeness in detail, we focus on some specific
diseases. A maximum connected component of given disease’s
genes is extracted from DAN and defined as gene module of this
kind of disease. We take endocrine disease and neurological
disease as examples. Both endocrine disease gene module and
neurological disease gene module are shown in Figure 4B.
Obviously, aging genes (nodes with black borders) make big
contribution to the connection between the two kinds of diseases.
MD means the genes involved in multiple diseases. Aging gene
ESR1 is a transcription factor that mediates the actions of
estrogen. ESR1 has been found to be upregulated in Alzheimer’s
disease [39] and also involved in breast cancer [40] and other
complex diseases. Here we assert that ESR1 is a key gene linking
endocrine disease and neurological disease. Further research on
this gene is needed to understand these two kinds of complex
diseases. Similarly, we consider immunological disease and
neurological disease in Figure 4C. From this figure, we can easily
conclude that aging genes FAS and APP are important to the
linkage of immunological and neurological diseases.
Discussion
We constructed a network connecting biological aging and
genetic diseases for the first time. This network provides a new
viewpoint for the aging disease association. According to the
analysis of the close relationship of aging and disease genes, we
explained and partially answered the basic question that why
diseases are always coupled with aging. Our analysis shows that
there are close relationships between aging genes and disease
genes, and provides biological insight into the basic process of
human body from network perspective.
The global feature of disease genes in human genome is a key
problem concerned by biologists and physicians. There are different
solutions or assumptions due to the limited data for this problem.
Before the work by Goh et al., the conventional understanding on
disease genes especially cancer genes is that they are in a central
position in the network. However, their work according to
combining disease genes and essential genes strikes this standpoint.
This kind of periphery viewpoint about diseases seems reasonable
from the evolutionary viewpoint. Lethal diseases are thought to be
eliminated by long time evolution pressure. However, people may
ask why a long time evolution history has not removed all diseases
from human beings.Bycontraries, itseemsthat the disease becomes
much more complicated and much more severe in advanced
organisms. To answer this question, we must combine another
important factor-aging. The force of natural selection declines with
age [41], so the close relationship between aging and diseases may
be one of the reasons to explain why diseases can avoid the choice
by evolution (refer to Supplementary Figure S5 for the properties
of human diseases, aging, housekeeping and essential genes.).
The closeness between different diseases defined based on
network is asymmetric. It in some sense reflects the real
relationship between them. We show that aging genes serves as
a bridge which has the function of linking different diseases, and
prove such a functional role of aging genes which is verified by
comparing with closeness in the network. From the viewpoint of
pathway, aging genes can be thought as a media of cross talking
between different diseases, where aging genes make a major
contribution in the linkage of different diseases.
We should note that potential sources of bias may exist, especially
in literature-curated networks, i.e. disease-causing proteins (genes)
mayhavehigherdegreessimplybecause they arebetterstudied.It is
very difficultfor ustototallyunderstand theprocess ofaging andthe
nature of diseases. Recently high-throughputtechnologies shed light
on the global behavior of biological systems, which provides
information and opportunity to conduct system-wide analysis, and
also gives some insight into the underlying biological mechanisms.
This work is motivated by such a trend and recent progress on this
area. Although this paper mainly focuses on genetic factors,
environment conditions also play an important role in all process
of aging and disorders, which we will study as a future topic.
Materials and Methods
The human aging genes
The aging genes were downloaded from GenAge [28,42] on
2008-5-1, which collected human aging genes after an extensive
review of the literature. Genes regulating aging in model organisms
or genes directly related to mammal (including humans) aging were
all identified. Considering that genes regulating aging in model
systems may not be related to human aging, they reviewed the
literature concerning human and mouse homologues of genes
identified in lower organisms. Genes influencing risk of age-
associated diseasesdo notnecessarily influenceaging,so aginggenes
are different from genes related to age-associated diseases. Each
gene was selected or excluded based on its association with aging in
the different model systems (there is some kind of conservation in
aging process between human and other species [43]), with priority
being given to organisms biologically and evolutionary more closely
related to humans. Among all the 243 aging genes obtained from
GenAge, 226 are included in the human PPI network.
Disease genes and classification of diseases
The disease genes and their classification were extracted from
Goh et al., 2007. All diseases reported in OMIM were manually
classified into 20 primary disorder classes based on the
physiological system affected by the disease. Diseases with distinct
multiple clinical features were assigned to the ‘‘multiple’’ class, and
31 diseases that can not be assigned to a clear class were annotated
into an ‘‘unclassified’’ class. Totally, there are 1,777 disease genes
(1317 in the PPI network), and 22 disease classes. We used all 22
classes to construct the DAN, but did not consider ‘‘multiple’’ class
and ‘‘unclassified’’ class in the following analysis.
Essential genes and housekeeping genes
Homologous data were retrieved from the Mouse Genome
Database (MGD), Mouse Genome Informatics (http://www.
informatics.jax.org) (2008-5-13). Two kinds of phenotypic data
are considered as lethality: lethality-postnatal (MP:0005373) and
lethality-prenatal/perinatal (MP:0005374). Totally we get 2,600
lethality genes, and 2,164 are in HPRD. Housekeeping genes are
defined as those genes that are almost expressed in all tissues. We
extract the gene list from supplementary information of [8], and
mapped Unigene ID to Entrez gene ID according to gene
The Disease-Aging Network
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enrichment ratio), and minus 10-based logarithm p-value is showed in the figure where values larger than four set to be four. (B–C) Examples show
the important functions of aging genes in connecting diseases. MD means that the genes are involved in multiple gene sets.
doi:10.1371/journal.pcbi.1000521.g004
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among them 960 are in HPRD.
PPI network
Human PPI network is from HPRD Release 7 [30]. We
extracted the maximum connected component. At last, the derived
network contains 9,045 proteins with 34,853 interactions.
Rate of gene evolution
The ratio dN=dS, the rate of DNA substitutions which affects
the amino-acid composition of the gene product (dN) to the rate of
DNA substitutions that are silent at the amino-acid level (dS), is
usually used to measure the rate of protein evolution [44]. The
value used in this paper is based on human-mouse orthologues.
Topological features of network
For each vertex in a network, degree di is the number of edges
incident to it. The clustering coefficient is usually used to quantify
how close its neighbors are to being a clique (complete graph). It is
defined by the proportion of links between the vertices within its
neighborhoods divided by the number of links that could possibly
exist between them, i.e., clci~
2ni
di(di{1)
, where ni is the number
of triangles incident to it. The topological coefficient is defined as
tci~
average(mij)
j
di
, where mij is the number of common vertexes
between i and j.
Centrality measures of nodes in network
There are several ways to measure the centrality of nodes in a
given network, i.e. degree centrality (DC), betweenness centrality
(BC), closeness centrality (CC), eigenvector centrality (EC),
PageRank (PC), subgraph centrality (SC) and information
centrality (IC). DC, which is a fundamental quantity describing
the topology of scale-free network, is defined by dci~
di
N{1
,
where di is the degree of ith vertex, N is the total number of nodes
in the network. BC which represents how influential a node is in
communicating between node pairs, is defined by bci~
2spi
N(N{1)
,
where spi is the number of shortest path across vertex i.C Ci s
defined as the mean geodesic distance (i.e the shortest path)
between a vertex and all other vertices reachable from it. EC is the
principal eigenvector of the adjacency matrix related to the
combined degree of the element and its neighbors. PC is the
damped random-walk based prestige-measure of Google related to
the principal eigenvector of the transition matrix describing the
damped random walk. SC is related to the closed walks starting
and ending at the given element. IC is the drop of graph
performance removing the given element or link.
p-value by overlapping
The following model has been used several times in this paper.
Consider that a set containing N elements has two subsets S1
and S2 with m and n elements respectively. We calculate the
probability that there are k overlapping elements with hypergeo-
metric distribution as follows:
P(X~k)~
m
k
  
N{m
n{k
  
N
n
   :
p-value by interacting partners
To test whether aging genes tend to interact with diseases, we
first calculate how many disease genes interact with one aging gene
on average. Then we test whether the average number is
statistically significant larger than the random cases. Here random
cases mean the average number of disease genes in 1,000 degree-
preserving random networks [45].
p-value by bridging feature of aging genes
When we delete the aging genes in our PPI network, closenesses
between diseases become smaller because the connectivity of the
network becomes weaker. But this cannot tell the particularity of
aging genes. To get a non-biased control set, we choose random
genes sets with matching degree as pseudo-aging genes. This is
implemented as follows:
Step1: For every aging gene we choose a candidate gene set, in
which each gene has almost the same degree with the aging gene.
We ensure that each candidate gene set has at least 10 genes.
Step2: Given the set of 226 aging genes, we randomly select a
gene from its corresponding candidate gene set as pseudo-aging
gene for every aging gene. As a result we get a set of 226 pseudo-
aging genes.
Step3: We repeat Step2 for 1000 times and generate a control
set of aging gene set.
The 1,000 groups of pseudo-aging genes are deleted from the
network respectively as random control to calculate the p-value.
Fold enrichment ratio (FER)
R~
O
E
, where O is the observed value and E is the expected
value.
Closeness between two diseases
For any two diseases di and dj, with disease genes gi1,   ,gini
and gj1,   ,gjnj respectively, we want to define association to
describe the possible relationship between them. Suppose disease
dj as a source, i.e. genes related to dj are abnormal (upregulated or
downregulated), then how much is di influenced? Considering the
disease information passed via disease genes through PPI network,
we let C(di/dj) denote di’s intensity of being influenced by dj.
The intensity is defined by
C(di/dj)~
1
ni
X ni
m~1
max
k~1,2,   ,nj
fc(gim,gjk)g
where ni is the total number of di’s disease genes, and c(gim,gjk) is
the closeness between two genes.
We can have several different ways to define c(gim,gjk). Here we
develop two network-based methods:
(1) The shortest path method:
The length of shortest path is an intuitive but efficient way to
describe the relationship between two nodes on a network. The
closeness of two genes can be got from the following transformation:
c(gim,gjk)~
1
1zd(gim,gjk)
,
where d(gim,gjk) is the length of shortest path between gim and gjk.
(2) The diffusion kernel method
The diffusion kernel is a random walk based method [46] and
recently its power in mining network topological information in
PPI networks [47] has been demonstrated. Our experiments show
that these two methods obtained almost the same result.
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Most of the experiments are executed on Matlab 2007-b, and
also some are on Cytoscape 2.6.1 [48]. GO analysis is based on
BINGO 2.0 [49].
Supporting Information
Table S1 Aging genes and their reasons to be selected in
GenAge
Found at: doi:10.1371/journal.pcbi.1000521.s001 (0.03 MB XLS)
Table S2 Disease genes and their classification
Found at: doi:10.1371/journal.pcbi.1000521.s002 (0.06 MB XLS)
Table S3 Cancer genes with degree 20–50 are significantly
closer to other disease genes than expected by chance, while
cancer genes with degree less than 20 or larger than 50 are close to
other disease genes but these relations are not statistically
significant
Found at: doi:10.1371/journal.pcbi.1000521.s003 (0.02 MB XLS)
Figure S1 Comparison of the centrality between aging genes and
disease genes with different measures:degree centrality (DC), which
is a fundamental quantity describing the topology of scale-free
network, can be interpreted as a measure of immediate influence.
Betweenness centrality (BC) represents how influential a node is in
communicating between node pairs. Closeness centrality (CC) is
definedas the mean geodesic distance (i.e the shortest path) between
a node and all other reachable nodes. Eigenvector centrality (EC) is
the principal eigenvector of the adjacency matrix related to the
combined degreeoftheelementanditsneighbors.PageRank(PC)is
related to the principal eigenvector of the transition matrix
describing the damped random walk. Subgraph centrality (SC) is
related to the closed walks starting and ending at the given element.
Information centrality (IC) is the drop of graph performance
removing the given element or link. Different kinds of centrality
measures all support our conclusion that aging genes show much
stronger centrality than disease genes. The corresponding p-values
of EC, PC, SC, IC, DC, BC and CC are respectively 6e-39, 1e-25,
5e-43, 8e-24, 8e-36, 2e-22, and 5e-42 (Wilcoxon rank sum test).
Found at: doi:10.1371/journal.pcbi.1000521.s004 (0.07 MB PDF)
Figure S2 (A)–(D) Venn graph of overlapping between aging
genes and diseases genes. Universal sets are all human genes, genes
with interactions in HPRD, non-essential genes in HPRD and all
gene interactions in HPRD respectively. (E) Fold enrichment ratio
and p-value of the overlapping. Both genes and gene interactions
show significant overlapping than random.
Found at: doi:10.1371/journal.pcbi.1000521.s005 (0.33 MB PDF)
Figure S3 Z-score of closeness between different diseases. Here,
we set values larger than four to be four to achieve better
visualization.
Found at: doi:10.1371/journal.pcbi.1000521.s006 (0.33 MB PDF)
Figure S4 The bridgeness of cancer genes in every pair of
diseases. Here, minus 10-based logarithm p-value is showed in the
figure where values larger than four set to be four to achieve better
visualization.
Found at: doi:10.1371/journal.pcbi.1000521.s007 (0.08 MB PDF)
Figure S5 The box plots of different features of five kinds of
gene sets in the human protein-protein interaction network. Aging
genes have much higher average values than other genes respect to
degree, betweenness centrality, clustering coefficients and close-
ness centrality.
Found at: doi:10.1371/journal.pcbi.1000521.s008 (0.08 MB PDF)
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